rs727504893
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_206933.4(USH2A):c.632G>A(p.Trp211*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000685 in 1,460,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_206933.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- retinitis pigmentosa 39Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.632G>A | p.Trp211* | stop_gained | Exon 3 of 72 | 1 | NM_206933.4 | ENSP00000305941.3 | ||
USH2A | ENST00000366942.3 | c.632G>A | p.Trp211* | stop_gained | Exon 3 of 21 | 1 | ENSP00000355909.3 | |||
USH2A | ENST00000674083.1 | c.632G>A | p.Trp211* | stop_gained | Exon 3 of 73 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460908Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726758 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Usher syndrome Pathogenic:1
Variant summary: USH2A c.632G>A (p.Trp211X) results in a premature termination codon and is predicted to cause absence of the protein due to nonsense mediated decay, a commonly known mechanism for disease. The variant was absent in 250800 control chromosomes (gnomAD). To our knowledge, no occurrence of c.632G>A in individuals affected with Usher Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. However, another variant resulting in the same amino acid change, c.633G>A (p.Trp211X) has been reported in the literature in at least one individual affected with Usher Syndrome (e.g. Bonnet_2016, PMID: 27460420). No submitters have cited clinical-significance assessments for c.632G>A to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -
Retinitis pigmentosa 39 Pathogenic:1
- -
Rare genetic deafness Pathogenic:1
The Trp211X variant in USH2A has not been previously reported in individuals wit h hearing loss or in large population studies. This nonsense variant leads to a premature termination codon at position 211, which is predicted to lead to a tru ncated or absent protein. In summary, this variant meets our criteria to be clas sified as pathogenic (http://pcpgm.partners.org/LMM). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at